G1 THERAPEUTICS INC's ticker is and the CUSIP is 3621LQ909. A total of 3 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,280 | -53.7% | 37,000 | -19.9% | 0.00% | – |
| Q2 2023 | $115,038 | +6.8% | 46,200 | +14.9% | 0.00% | – |
| Q1 2023 | $107,736 | +64.0% | 40,200 | +232.2% | 0.00% | – |
| Q4 2022 | $65,703 | -56.8% | 12,100 | -0.8% | 0.00% | – |
| Q3 2022 | $152,000 | -28.6% | 12,200 | -71.8% | 0.00% | – |
| Q2 2022 | $213,000 | -7.4% | 43,200 | +42.6% | 0.00% | – |
| Q1 2022 | $230,000 | -34.7% | 30,300 | -12.2% | 0.00% | – |
| Q4 2021 | $352,000 | -56.9% | 34,500 | -43.3% | 0.00% | -100.0% |
| Q3 2021 | $817,000 | -64.9% | 60,900 | -42.7% | 0.00% | -66.7% |
| Q2 2021 | $2,330,000 | -6.5% | 106,200 | +2.5% | 0.00% | -25.0% |
| Q1 2021 | $2,493,000 | +881.5% | 103,600 | +634.8% | 0.00% | – |
| Q4 2020 | $254,000 | – | 14,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 40,200 | $107,736 | 0.00% |
| SIMPLEX TRADING, LLC | 30,100 | $80 | 0.00% |